Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention - Mueck, W; Lensing, AW; Agnelli, G (Clin Pharmacokinet, 2011)
et al.